AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Begroease 25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Mirabegron (25mg)

Overview Begroease 25mg Tablet ER

UroEase 25mg Extended-Release tablets alleviate overactive bladder symptoms such as heightened urination frequency, urgency, and incontinence. This medication promotes bladder muscle relaxation, improving urine storage capacity. Always adhere to your doctor's prescribed dosage and duration. UroEase 25mg ER may be taken with or without food; swallow the tablet whole – do not crush or chew. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your physician immediately. Before starting treatment, disclose all current medications and pre-existing health conditions, including pregnancy or breastfeeding status. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their doctor.

Uses of Begroease 25mg Tablet ER

Managing overactive bladder (OAB) symptoms

Major Benefits of Begroease 25mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Begroease 25mg Extended-Release tablets can be consumed with or without food, however, consistent timing is recommended.

Common Side effects of Begroease 25mg Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Begroease 25mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Begroease 25mg Extended-Release tablets can be administered with or without food, however, consistent timing is recommended.

How Begroease 25mg Tablet ER works:

Begroease 25mg Extended-Release tablets utilize a beta-3 adrenergic agonist mechanism. This stimulates bladder beta-3 receptors, resulting in detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Begroease 25mg Extended-Release tablets with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Begroease 25mg tablets might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Begroease 25mg tablets are likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Begroease 25mg Extended-Release Tablets.

KidneyKidneyCAUTION

Exercise caution when prescribing Begroease 25mg Extended-Release tablets to individuals with advanced renal impairment. Dosage modification of Begroease 25mg Extended-Release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when administering Begroease 25mg Extended-Release tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Begroease 25mg Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Begroease 25mg Tablet ER :

Should you forget a Begroease 25mg Extended-Release Tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Begroease 25mg Tablet ER

LabelValue
Chemical Category Anilide-based compound
Developing Habits No.
Treatment Category Urology
Action Class Beta-3 agonist for bladder control

FAQs on Begroease 25mg Tablet ER

Begroease 25mg Tablet ER's full effects may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4–8 weeks, depending on individual response.
Continue taking your Begroease 25mg Tablet ER, even if your symptoms improve. This medication doesn't cure overactive bladder; it manages urgency, frequency, and incontinence. Stopping treatment could bring back your symptoms.
Begroease 25mg ER tablets shouldn't interfere with your sleep. However, discuss any sleep problems with your doctor.
Begroease 25mg Tablet ER should not be used in children under 18 years of age due to a lack of studied efficacy and safety data in this population.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not curing it. Intermittent use prevents your bladder from adapting fully, hindering effectiveness and leading to symptom recurrence.
Begroease 25mg Tablet ER may cause kidney, ureter, bladder, or urethra infection, though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and report any kidney-related adverse effects to their physician.
Caution is advised when taking Begroease 25mg Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended, as Begroease 25mg Tablet ER may raise blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, even without symptoms. Begroease 25mg Tablet ER overdose can raise heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Begroease 25mg Tablet ER
189
MRP 230
17% off